Impact of Apathy on Caregiving in HD. Version 1

Sponsor
University of East Anglia (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05913154
Collaborator
University of Cambridge (Other)
20
1
7.2
2.8

Study Details

Study Description

Brief Summary

Huntington's disease (HD) can affect motivation. People with HD may not wash often, keep their house clean and tidy, or eating healthy food. This loss of motivation, or apathy, can also affect the way they talk to people and how willing they are to be in social situations.

There are thought to be four different subtypes of apathy. These include reduced (1) motivation for planning and organising, (2) emotional reactions, (3) thoughts and actions and (4) social interaction.

It is clear from talking to patients and their families in clinic that apathy has a big impact. It is often a source of distress for the people around the patient, who are trying to support and care for them. We know from previous research, that having good social support helps people with Huntington's disease to live independently for longer. This research aims to understand the ways in which apathy can impact the levels of burden felt by caregivers of people with HD.

Caregivers will be asked to take part in a single interview. They will be asked questions about caring for someone with apathy. There will also be the opportunity to share their own first-hand experiences. These interviews will be analysed for common themes using framework analysis. Attention will be given to the relationship between burden and the different types of apathy.

Understanding the factors that lead to increased caregiver burden is the first step towards finding way to support caregivers of people with HD.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    20 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    A Qualitative Exploration of the Impact of Apathy on the Caregiving Relationship in the Context of Huntington's Disease
    Actual Study Start Date :
    Apr 26, 2023
    Anticipated Primary Completion Date :
    Dec 1, 2023
    Anticipated Study Completion Date :
    Dec 1, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Cognitive/executive apathy

    Behavioural/inhibition apathy

    Emotional apathy

    Social apathy

    Outcome Measures

    Primary Outcome Measures

    1. Themes [1 day (Outcomes will be measured once, at the time of the interview)]

      Synthesised themes generated from the the qualitative interviews with companions

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    Participants will be included in the study if:
    • They hold significant caring responsibilities for someone with clinically manifest HD

    • The person they care for scores above the abnormality cut-off determined for HD on one or more subscale of the Dimensional Apathy Scale - Companion version, or the proposed clinical cut-off for the Apathy Motivational Index - Companion.

    • They are 18 years or older and able to give valid, informed consent for study participation.

    Exclusion Criteria:
    Individuals will be excluded from the study is they:
    • Have a lack of spoken English, sufficient to affect their understanding of the interview questions or compromise their ability to express their opinions.

    • Did not consent to the interview being recorded.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of East Anglia Norwich Norfole United Kingdom

    Sponsors and Collaborators

    • University of East Anglia
    • University of Cambridge

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of East Anglia
    ClinicalTrials.gov Identifier:
    NCT05913154
    Other Study ID Numbers:
    • 319976
    First Posted:
    Jun 22, 2023
    Last Update Posted:
    Jun 22, 2023
    Last Verified:
    Mar 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 22, 2023